BirchBioMed (Direct Listing)
Note: This is NOT an IPO. This is a NASDAQ Direct Listing. Maxim Group is the financial advisor. BirchBioMed’s registered stockholders have registered to offer up to 29.9 million shares of common stock in the Direct Listing. The company will not raise new capital. (Incorporated in British Columbia) We are a Phase 2B/Phase 3 company […]
August 17, 2026 Read More